Canada markets closed

Nanalysis Scientific Corp. (NSCI.V)

TSXV - TSXV Delayed Price. Currency in CAD
Add to watchlist
0.52000.0000 (0.00%)
At close: 2:30PM EDT
Full screen
Previous Close0.5200
Open0.5300
Bid0.5100 x N/A
Ask0.5300 x N/A
Day's Range0.5200 - 0.5400
52 Week Range0.3500 - 0.7900
Volume20,000
Avg. Volume58,541
Market Cap34.083M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0390
Earnings DateAug. 20, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Baystreet

    Stocks in play: Nanalysis Scientific Corp.

    Approved on July 1 the granting of 40,000 restricted share units to each director of the Company pursuant ...

  • Nanalysis Scientific Corp. Announces Grant of Restricted Share Units
    CNW Group

    Nanalysis Scientific Corp. Announces Grant of Restricted Share Units

    CALGARY, AB , July 2, 2020 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) is pleased to announce that the Board of Directors ...

  • Nanalysis Scientific Corp. Reports First Quarter 2020 Results
    CNW Group

    Nanalysis Scientific Corp. Reports First Quarter 2020 Results

    RS2D also expands the Company's product portfolio with its Pulse console for high-field NMR systems. Full integration of the companies has been completed, highlighted by two RS2D executives taking important leadership positions: Remy Schimpf as Senior VP of Sales, and Julien Muller as Chief Technology Officer. For the three months ended March 31, 2020, the Company reported consolidated revenue of $1,523k, a decrease of $542k over the $2,065k for the comparable period ended March 31, 2019.